Polypeptide and use thereof
AssigneeGenoimmune Therapeutics Co., Ltd.
InventorsShuntao Luo, Xiumei Lin, Ting An, Bo Li, Yong Hou
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenoimmune Therapeutics Co., Ltd.
InventorsShuntao Luo, Xiumei Lin, Ting An, Bo Li, Yong Hou
Estimating the term…
Provided are a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid, an antigen-presenting cell presenting the polypeptide on the surface of the cell, and immune effector cell thereof, a pharmaceutical composition containing the polypeptide, a vaccine containing the nucleic acid, the nucleic acid construct, the expression vector, the host cell, the antigen-presenting cell, and the immune effector cell, and an antibody recognizing the polypeptide. Also provided is a therapeutic method using the polypeptide, the nucleic acid, the pharmaceutical composition, the vaccine, and the antibody. Also provided are a diagnosis method and diagnosis apparatus for detecting the described polypeptide. Also provided is an application of the polypeptide in preparing a vaccine, a tumor diagnosis kit, or a pharmaceutical composition, and an application of the polypeptide or the nucleic acid as a test target in tumor diagnosis.
An isolated polypeptide selected from SEQ ID NO:
A vaccine comprising an isolated polypeptide as an active pharmaceutical ingredient and a pharmaceutically acceptable adjuvant in an amount sufficient to stimulate a host immune response to the polypeptide, wherein the polypeptide is selected from the group consisting of:
Dependencies are inferred from the claim text.